Detalles de la búsqueda
1.
Mind your words: Oncologists' communication that potentially harms patients with advanced cancer: A survey on patient perspectives.
Cancer
; 128(5): 1133-1140, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34762305
2.
Addressing challenges in information-provision: a qualitative study among oncologists and women with advanced breast cancer.
BMC Palliat Care
; 20(1): 142, 2021 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34521393
3.
Surgical Complications of Skin-Sparing Mastectomy and Immediate Implant-Based Breast Reconstruction in Women Concurrently Treated With Adjuvant Chemotherapy for Breast Cancer.
Ann Plast Surg
; 86(2): 146-150, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568758
4.
Reducing uncertainty: motivations and consequences of seeking a second opinion in oncology.
Acta Oncol
; 59(12): 1512-1519, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32702254
5.
The power of clinician-expressed empathy to increase information recall in advanced breast cancer care: an observational study in clinical care, exploring the mediating role of anxiety.
Patient Educ Couns
; 104(5): 1109-1115, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33168460
6.
Patient-provider communication during second opinion consultations in oncology.
Patient Educ Couns
; 104(10): 2490-2497, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33744055
7.
Oncologists' Communication About Uncertain Information in Second Opinion Consultations: A Focused Qualitative Analysis.
Front Psychol
; 12: 635422, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135806
8.
Cancer patients' trust as a motivator to seek a second opinion and its effects on trust.
Psychol Health
; : 1-19, 2021 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34894900
9.
Patients' and Clinicians' Perceptions of Clinician-Expressed Empathy in Advanced Cancer Consultations and Associations with Patient Outcomes.
Palliat Med Rep
; 1(1): 76-83, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-34223461
10.
Neutrophil Recovery in Breast Cancer Patients Receiving Docetaxel-Containing Chemotherapy with and without Granulocyte Colony-Stimulating Factor Prophylaxis.
Oncology
; 93(5): 323-328, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28848182
11.
The Use of Expectancy and Empathy When Communicating With Patients With Advanced Breast Cancer; an Observational Study of Clinician-Patient Consultations.
Front Psychiatry
; 10: 464, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31379614
12.
Toxicity of dual HER2-blockade with pertuzumab added to anthracycline versus non-anthracycline containing chemotherapy as neoadjuvant treatment in HER2-positive breast cancer: The TRAIN-2 study.
Breast
; 29: 153-9, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27498129
13.
Intensive care admission of cancer patients: a comparative analysis.
Cancer Med
; 4(7): 966-76, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25891471
14.
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.
J Clin Oncol
; 31(34): 4283-9, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24166522
15.
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.
J Clin Oncol
; 31(34): 4290-6, 2013 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23630211
16.
Having a Conversation With a Patient With Incurable Cancer-Just Another Protocol?
JAMA Oncol
; 3(10): 1305-1306, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28199470
17.
Weekly docetaxel in metastatic breast cancer patients: no superior benefits compared to three-weekly docetaxel.
Eur J Cancer
; 47(9): 1355-62, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21251813
18.
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Clin Cancer Res
; 17(11): 3600-18, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21505063
19.
Randomized phase II study comparing efficacy and safety of combination-therapy trastuzumab and docetaxel vs. sequential therapy of trastuzumab followed by docetaxel alone at progression as first-line chemotherapy in patients with HER2+ metastatic breast cancer: HERTAX trial.
Clin Breast Cancer
; 11(2): 103-13, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21569996
Resultados
1 -
19
de 19
1
Próxima >
>>